@article{50143,
      recid = {50143},
      author = {Ghidini, Gustavo, and Piselli, Riccardo,},
      title = {A Regulatory Governance Perspective on IP and Access to  Medicines : A Fresh Look Into the TRIPS Agreement.},
      pages = {1 online resource (pages  817-823)},
      abstract = {As concerns the relationship between the Global South and  the developed countries, the TRIPS Agreement provides a  robust protection of IP. This might result in a weaker  protection of fundamental rights, such as health, in those  countries that do not possess the necessary know-how and  industrial capacity to manufacture essential medicines. The  recent Decision adopted at the 12th WTO Ministerial  Conference provides the opportunity to focus again on the  topic and deal with the issue of the clash between IP and  the national interests of the least developed countries.  Instead of addressing the problem by looking at the  well-known flexibilities/inflexibilities of the Agreement,  this paper proposes a different methodological approach  that builds on the flourishing literature on regulatory  governance. To this end, a multi-dimensional regulatory  approach is suggested that simultaneously exploits a matrix  of normative, market-based and cooperative instruments.  While we wait for a more structural normative reform, a  similar perspective not only proves to be useful from a  theoretical perspective, but could also contribute to  shedding a new light on the TRIPS Agreement.},
      url = {http://tind.wipo.int/record/50143},
      doi = {https://doi.org/10.1093/grurint/ikae092},
}